Inflammatory pathways and cardiac repair: the affliction of infarction
暂无分享,去创建一个
[1] P. Libby,et al. Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. , 1999, Circulation.
[2] M. Martone,et al. Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy , 1999, Nature Medicine.
[3] J. Ross,et al. Loss of a gp130 Cardiac Muscle Cell Survival Pathway Is a Critical Event in the Onset of Heart Failure during Biomechanical Stress , 1999, Cell.
[4] D. Hanahan,et al. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. , 1999, Genes & development.
[5] K. Chien,et al. Stress Pathways and Heart Failure , 1999, Cell.
[6] P. Carmeliet,et al. Development and disease in proteinase-deficient mice: role of the plasminogen, matrix metalloproteinase and coagulation system. , 1998, Thrombosis research.
[7] K. Chien,et al. Signaling pathways for cardiac hypertrophy and failure. , 1999, The New England journal of medicine.
[8] A. Luttun,et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure , 1999, Nature Medicine.
[9] J. Ross,et al. Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[10] M. Daemen,et al. Chronic myocardial infarction in the mouse: cardiac structural and functional changes. , 1999, Cardiovascular research.
[11] P. Doevendans,et al. Cardiovascular phenotyping in mice. , 1998, Cardiovascular research.
[12] M. Zile,et al. Matrix metalloproteinase inhibition during the development of congestive heart failure : effects on left ventricular dimensions and function. , 1999, Circulation research.